 new way evaluating tumors soon help cancer patients identify underlying genetic disease best possible treatment single set begin clinical trials using comprehensive testing method looks known genes active tumor new method guide patients right drug earlier potentially replacing current tests known companion diagnostics look specific biological trait presence predict new class drugs called targeted therapies work particular broader tests used quickly identify patients benefit experimental drugs tested clinical trials health officials future direction cancer diagnostics really moving away drug companion diagnostic food drug administration oncology advanced melanoma example half patients tumors mutation gene makes drug called blocks pathway time drug patients need evaluated companion diagnostic test tests cases requires companion diagnostics drug approval process broader testing model opens door additional players diagnostics space including foundation medicine thermo fisher’s life trial starting later month example patients squamous cell carcinoma lung recommended experimental treatments based genes active foundation medicine sequencing platform used screen 6,000 lung cancer patients lung master protocol trial known place research centers partnership national cancer institute arm unit similar effort called national lung matrix trial organized cancer research set start taking patients august id conference fall discuss plans trial metastatic breast cancer new paradigm ways chairperson founder friends cancer research organizing lung cancer trial revolutionizing genetic testing patients trial tissue mace senior vice president clinical development cancer business single test looking single biological marker sense targeted cancer drugs exploit specific weaknesses tumors past years identified potential targets drugs molecules involved critical functions cancer cell relevant able tissue test tissue tests cell lung cancer example dozen different molecular abnormalities known influence tumor miller foundation medicine chief medical officer drugs win approval doctors need run tests tiny scrap tumor tissue scarcity real issue issue chief medical officer knows father battling second round lung cancer biopsies using long needle process produces tiny tissue sample fixed tissue maximize diagnostics company companion diagnostic tests market including recently approved cancer drug invested new testing platform privately held company expanded partnership companies plan use new platform analyze targeting multiple molecular pathways active common developing companion tests half experimental medicines pipeline evaluating tests look target time spokeswoman reporting editing martin scientists prize physics revealing unusual states matter leading advances electronics aid researchers trying develop quantum japan prize medicine experiments yeast exposed key mechanism body defenses cells degrade recycle components